The future of B cell-targeted therapies in Sjögren's syndrome

Author： Cornec Divi   Saraux Alain   Devauchelle-Pensec Valérie   Clodic Coralie   Pers Jacques-Olivier  

Publisher： Future Medicine

ISSN： 1750-743X

Source： Immunotherapy, Vol.5, Iss.6, 2013-06, pp. : 639-646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular-Targeted and Cell-Based Therapies for Sjogren’s Syndrome

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

The current status and future impact of targeted therapies in non-Hodgkin lymphoma

By Ujjani Chaitra   Cheson Bruce D  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 191-203

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Applications for Stem Cell Therapies in Spine Surgery

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 5, 2013-01 ,pp. : 381-393

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Future Applications for Stem Cell Therapies in Spine Surgery

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 5, 2013-07 ,pp. : 381-393

Bentham Science Publishers

Access to resources Recommend Favorite

BCR/ABL1 Fusion Transcripts Generated from Alternative Splicing: Implications for Future Targeted Therapies in Ph+ Leukaemias

By  

Current Molecular Medicine, Vol. 12, Iss. 5, 2012-06 ,pp. : 547-565

Bentham Science Publishers

Access to resources Recommend Favorite